Medibank Director Lisa McIntyre Increases Indirect Shareholding

The latest update is out from Medibank Private ( (AU:MPL) ).

Medibank Private has reported a change in director Lisa McIntyre’s relevant interest in the company’s securities, in line with Australian Securities Exchange disclosure requirements. The notice details that McIntyre has acquired Medibank ordinary shares indirectly through an entity associated with her, signalling an update to her equity position in the health insurer.

According to the filing, 22,370 Medibank ordinary shares were purchased on 23 February 2026 at a price of $4.48 per share via 21 Cows Pty Ltd , taking McIntyre’s indirect holding from zero to 22,370 shares. While modest in scale, the acquisition aligns director and shareholder interests and provides investors with greater transparency over board-level ownership in the company.

The most recent analyst rating on (AU:MPL) stock is a Hold with a A$4.80 price target. To see the full list of analyst forecasts on Medibank Private stock, see the AU:MPL Stock Forecast page.

More about Medibank Private

Medibank Private Limited is an Australian private health insurance company that offers health cover and related services to consumers across the country. The group focuses on providing hospital and extras policies, along with health and wellbeing programs, and is listed on the Australian Securities Exchange, where its shares are actively traded by institutional and retail investors.

YTD Price Performance: -6.81%

Average Trading Volume: 6,468,424

Technical Sentiment Signal: Buy

Current Market Cap: A$12.06B

Learn more about MPL stock on TipRanks’ Stock Analysis page.